Altered mucin glycosylation is observed in human gastric cancer and precancerous lesions, where changes in O-glycan structures affect bacterial adhesion, immune recognition, and epithelial barrier function (Rossez et al., 2012; Jin et al., 2017; Freitas et al., 2019). Here, MUC5AC is linked to gastric cancer.